UK Vaccine Maker Nets £60M In Shares Sale To Boost Growth
Oxford Biomedica PLC said on Friday that it has conditionally raised approximately £60 million ($81 million) from selling its shares, which the British biopharmaceutical firm plans to invest in improving productivity....To view the full article, register now.
Already a subscriber? Click here to view full article